Medicare bureaucrats wreck the medical equipment

market.

 

Sometime late this summer—the Friday before Labor Day if historical patterns hold—the Centers for Medicare

and Medicaid Services (CMS) will announce the beginning of something called Medicare Round Two of “the

Competitive Bidding Program for certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies.”

Although it sounds obscure, this bidding process’s manifest flaws could have serious consequences for just

about every American who needs medical care. Shortages of vital devices could develop, medical supply

companies could go out of business, medical innovation could slow, and, if things go as badly as some

economists think they will, health care costs could skyrocket as the direct result of a program intended to

control them.

The story of the bidding process for what insiders call DMEPOS provides a fascinating case history of how

broadly supported “good government” schemes can have serious negative consequences in the hands of

ambitious bureaucrats. Let’s begin with some background. Durable medical equipment, prosthetics, orthotics,

and supplies, i.e., DMEPOS, are goods used primarily outside of hospitals. The category includes everything

from crutches to pacemakers. DMEPOS are mainly distributed through small “home care/durable medical

equipment” businesses that earn most of their revenue through “market rate” reimbursements under the

Medicare program. The current purchasing process has problems: Among other things, prices for the same

equipment differ quite a bit between regions, invoices rarely track manufacturing costs, and quality problems

crop up more frequently than they should.

In an effort to save money for Medicare while boosting quality, Medicare began full-scale competitive bidding

for some products under the 2003 law adding prescription drug coverage to Medicare. Under that law and an

additional package of Medicare tweaks passed in 2008, the bidding process would begin in a few areas and, if

successful, expand. (The 2010 health care law accelerates this expansion.) At the time, it seemed like common

sense, good-government thinking. Supporters of bidding processes included the George W. Bush

administration, then Senate majority leader Bill Frist, and Frist’s late Democratic colleague Ted Kennedy. CMS

claims it will obtain average savings of nearly 20 percent, or about $1.5 billion out of the more than $8 billion

Medicare spent on DMEPOS in 2009.

Despite a long buildup period, however, nobody paid much attention to the process until CMS announced a

plan for a bidding system that raised questions for just about every expert that has looked at it.

“Neither I nor anyone else have ever seen any bidding process anywhere that works this way,” says University

of Maryland professor Peter Cramton, an economist who has closely followed the Medicare bidding process.

And nearly 250 university and industry economists who study market-design economics have signed Cramtondrafted

letters to the president and CMS expressing grave concerns about the process and suggesting that it

be halted until its flaws can be worked out. (There’s no groundswell of academic support on the other side.)

The fundamental problem lies in the way that CMS’s market design crashes the established procedures for

government contract bidding. In a conventional bidding process for a government contract, qualified providers

submit bids offering specific quantities of a product at a particular price. The bidding process ends when the

total that the providers offer equals expected demand. This is called the “market clearing price.” If, for example,

CMS decides there’s a need for 100 walkers and gets bids of 25 walkers for $90 each, 25 walkers for $110

each, 50 walkers for $140 each, and 100 walkers for $150 each, it would establish a “clearing price” of $140,

hold all bidders to their bids, and decline to do business with the company that wanted $150. This process

becomes considerably more complex in real-world settings, but its fundamental efficiency in meeting demand

at the lowest cost ranks among the best-established conclusions in the field.

While it takes bids in a normal fashion, however, the CMS process insists that Medicare will pay everyone the

median of the “winning” prices. ($110 rather than $140 in the above example.) As a result, some bidders will be

paid less than they bid while others will be paid more. Unlike in a conventional government bidding process,

CMS neither requires bidders to prove they can deliver a product before bidding nor to actually deliver it

afterwards. And unlike all other government auctions outside of the national security realm, CMS reveals little

besides winners’ names to the public.

All these features could cause major problems. Since bidders don’t have to honor their bids or prove they can

meet them in the first place, they have enormous incentives to bid less than their actual costs, because doing

so gives them a zero-risk option to sell to CMS at a price that may be higher than the bid anyway. Since CMS

pays less than the likely-to-be-low “clearing price,” however, the system essentially guarantees that some will

have to sell at a loss or drop out and thereby threaten their own survival. Finally, since nearly everything is kept

secret, CMS’s own officials are free to manipulate contracts however they want. The result is a disaster waiting

to happen for the market as a whole.

In the trial areas, problems have already emerged. Diabetics have run into difficulty getting supplies that work

with their testing meters and CMS has had to rejigger delivery quantities for almost every major item it has put

out for bids. While these short-term fixes have prevented calamity, the fragile, nearly arbitrary process that now

exists could show real strains as soon as the “round two” process expands current practices to a total of 91

metropolitan areas that collectively contain almost the entire population.

In fact, just about every independent study of the process makes decidedly dour predictions. One report from

the Pacific Research Institute finds that CMS’s methods could reduce investment in medical device markets by

as much as $3.1 billion over a 10-year period (essentially stopping the development of new high-tech devices)

and cost $50 billion in terms of reduced life expectancy. Another report from the American Consumer Institute

finds that the process’s consequences for one category of equipment—vacuum pumps that help heal serious

wounds—would increase medical costs by $6.8 billion if it slows the technology’s rollout. “The CMS bidding

process is so flawed that it will fail to find sustainable market prices for medical equipment,” says Steve

Pociask, ACI’s chief economist and the study’s author. But CMS has given every indication it plans to push

forward with the process unchanged.

And that’s where the bureaucratic interests come in. Since the process puts low prices above all other

considerations, it will almost certainly produce savings of more than the 20 percent that experiments have

shown, and its designers will look very smart. With only a few areas and a few classes of products in play,

however, firms may have been willing to take losses up until now just to stay in the running. The people running

the program at CMS probably hope they will emerge looking like geniuses who saved taxpayers billions, while

the home care industry will get the blame as quality falls, shortages develop, deliveries become irregular,

innovation ceases, and more people end up in hospitals.

Cramton adds an important note. “It’s rare to see something like this happening in the absence of an organized

interest group on the other side,” he told me. “Usually somebody benefits from the flaws in a process. Here, no

special interest group benefits.” Unless, of course, one believes the CMS’s own leadership ought to be counted

as another special interest group with an agenda all its own.

paid less than they bid while others will be paid more. Unlike in a conventional government bidding process,

CMS neither requires bidders to prove they can deliver a product before bidding nor to actually deliver it

afterwards. And unlike all other government auctions outside of the national security realm, CMS reveals little

besides winners’ names to the public.

All these features could cause major problems. Since bidders don’t have to honor their bids or prove they can

meet them in the first place, they have enormous incentives to bid less than their actual costs, because doing

so gives them a zero-risk option to sell to CMS at a price that may be higher than the bid anyway. Since CMS

pays less than the likely-to-be-low “clearing price,” however, the system essentially guarantees that some will

have to sell at a loss or drop out and thereby threaten their own survival. Finally, since nearly everything is kept

secret, CMS’s own officials are free to manipulate contracts however they want. The result is a disaster waiting

to happen for the market as a whole.

In the trial areas, problems have already emerged. Diabetics have run into difficulty getting supplies that work

with their testing meters and CMS has had to rejigger delivery quantities for almost every major item it has put

out for bids. While these short-term fixes have prevented calamity, the fragile, nearly arbitrary process that now

exists could show real strains as soon as the “round two” process expands current practices to a total of 91

metropolitan areas that collectively contain almost the entire population.

In fact, just about every independent study of the process makes decidedly dour predictions. One report from

the Pacific Research Institute finds that CMS’s methods could reduce investment in medical device markets by

as much as $3.1 billion over a 10-year period (essentially stopping the development of new high-tech devices)

and cost $50 billion in terms of reduced life expectancy. Another report from the American Consumer Institute

finds that the process’s consequences for one category of equipment—vacuum pumps that help heal serious

wounds—would increase medical costs by $6.8 billion if it slows the technology’s rollout. “The CMS bidding

process is so flawed that it will fail to find sustainable market prices for medical equipment,” says Steve

Pociask, ACI’s chief economist and the study’s author. But CMS has given every indication it plans to push

forward with the process unchanged.

And that’s where the bureaucratic interests come in. Since the process puts low prices above all other

considerations, it will almost certainly produce savings of more than the 20 percent that experiments have

shown, and its designers will look very smart. With only a few areas and a few classes of products in play,

however, firms may have been willing to take losses up until now just to stay in the running. The people running

the program at CMS probably hope they will emerge looking like geniuses who saved taxpayers billions, while

the home care industry will get the blame as quality falls, shortages develop, deliveries become irregular,

innovation ceases, and more people end up in hospitals.

Cramton adds an important note. “It’s rare to see something like this happening in the absence of an organized

interest group on the other side,” he told me. “Usually somebody benefits from the flaws in a process. Here, no

special interest group benefits.” Unless, of course, one believes the CMS’s own leadership ought to be counted

as another special interest group with an agenda all its own.

of the “winning” prices. ($110 rather than $140 in the above example.) As a result, some bidders will be

paid less than they bid while others will be paid more. Unlike in a conventional government bidding process,

CMS neither requires bidders to prove they can deliver a product before bidding nor to actually deliver it

afterwards. And unlike all other government auctions outside of the national security realm, CMS reveals little

besides winners’ names to the public.

All these features could cause major problems. Since bidders don’t have to honor their bids or prove they can

meet them in the first place, they have enormous incentives to bid less than their actual costs, because doing

so gives them a zero-risk option to sell to CMS at a price that may be higher than the bid anyway. Since CMS

pays less than the likely-to-be-low “clearing price,” however, the system essentially guarantees that some will

have to sell at a loss or drop out and thereby threaten their own survival. Finally, since nearly everything is kept

secret, CMS’s own officials are free to manipulate contracts however they want. The result is a disaster waiting

to happen for the market as a whole.

In the trial areas, problems have already emerged. Diabetics have run into difficulty getting supplies that work

with their testing meters and CMS has had to rejigger delivery quantities for almost every major item it has put

out for bids. While these short-term fixes have prevented calamity, the fragile, nearly arbitrary process that now

exists could show real strains as soon as the “round two” process expands current practices to a total of 91

metropolitan areas that collectively contain almost the entire population.

In fact, just about every independent study of the process makes decidedly dour predictions. One report from

the Pacific Research Institute finds that CMS’s methods could reduce investment in medical device markets by

as much as $3.1 billion over a 10-year period (essentially stopping the development of new high-tech devices)

and cost $50 billion in terms of reduced life expectancy. Another report from the American Consumer Institute

finds that the process’s consequences for one category of equipment—vacuum pumps that help heal serious

wounds—would increase medical costs by $6.8 billion if it slows the technology’s rollout. “The CMS bidding

process is so flawed that it will fail to find sustainable market prices for medical equipment,” says Steve

Pociask, ACI’s chief economist and the study’s author. But CMS has given every indication it plans to push

forward with the process unchanged.

And that’s where the bureaucratic interests come in. Since the process puts low prices above all other

considerations, it will almost certainly produce savings of more than the 20 percent that experiments have

shown, and its designers will look very smart. With only a few areas and a few classes of products in play,

however, firms may have been willing to take losses up until now just to stay in the running. The people running

the program at CMS probably hope they will emerge looking like geniuses who saved taxpayers billions, while

the home care industry will get the blame as quality falls, shortages develop, deliveries become irregular,

innovation ceases, and more people end up in hospitals.

Cramton adds an important note. “It’s rare to see something like this happening in the absence of an organized

interest group on the other side,” he told me. “Usually somebody benefits from the flaws in a process. Here, no

special interest group benefits.” Unless, of course, one believes the CMS’s own leadership ought to be counted

as another special interest group with an agenda all its own.

Here is another reason why Medicare is in shambles. 

Our current system needs to be reformed in some capacity. But, we need to take a couple steps back and see what the real problems are first.  There is way too much FRAUD and ABUSE going on in this industry. 
Lowering prices on medical equipment, capping products and stopping patients from their right to choose which medical supply company that they want to use is not the answer.

Here is another black eye to our industry.

Robert Saul and his wife allegedly thought they could get rich by giving people expensive power wheelchairs and other medical equipment - equipment they didn't need - and falsely billing Medicare.

And they thought they had their bases covered by allegedly telling baffled recipients that Philadelphia was giving out $3,200 wheelchairs for free, or having sources in doctors' offices intercepting phone calls from confused patients.

But the alleged scheme fell apart, according to U.S. Attorney Michael L. Levy.

Saul, 36, and his wife, Sheila, 51, were charged yesterday by the U.S. Attorney's Office with defrauding Medicare and other programs by submitting more than $1.2 million in bogus claims.

Saul and his wife, who both live in Philadelphia, own R&V Medical Supplies, which is located on the 11th floor at 1420 Walnut St., in Center City. The company is still in business.

The Sauls did not respond to requests for comment yesterday.

Also charged yesterday were Lisa Burnett, 40, of Philadelphia, and Carol Mason, 57, of Norristown.

Burnett and Mason worked at a Philadelphia nonprofit that provided service to seniors and the disabled. They allegedly provided the Sauls with client information that was used to bill Medicare for unneeded medical supplies, and for which they were paid kickbacks.

In separate court filings, Susan Landolf, 27, and Debra Stallings, 43, both of Philadelphia, also were charged with participating in the scheme. Landolf worked at a medical clinic and then at R&V. Stallings worked at a private medical practice. Since they were charged in criminal informations, it is likely they have negotiated guilty pleas.

"This case involves breaches of trust at every level: From the medical office employees who sold patients' identity information, to the people charged today who used the Medicare Trust as their personal ATMs," Levy said.

"Any Medicare beneficiary who gets equipment that they know nothing about, or who sees payments for equipment on their explanations of benefits that they do not recognize, should contact the number on the explanation of benefits forms immediately to report it," Levy said.

Andy Scolnick, VP

Seventh Street Medical Supply, Inc

307 E. Pennsylvania Blvd.

Feasterville, PA 19053

(215) 396-2450

www.seventhstreetmedicalsupply.com

info@seventhstreetmedicalsupply.com

This is why our healthcare is in shambles. It is people like this that need to be banned from doing any type of business in the healthcare profession. A slap on the wrist is not acceptable.

FORT LAUDERDALE, Fla. — Federal agents arrested 26 suspects in three states Tuesday, including a doctor and nurses, in a major crackdown on Medicare fraud totaling $61 million in separate scams.

Arrests in Miami, Brooklyn and Detroit included a Florida doctor accused of running a $40 million home health care scheme that falsely listed patients as blind diabetics so that he could bill for twice-daily nurse visits.

The U.S. Department of Justice and U.S. Department of Health and Human Services said the indicted suspects lined up bogus patients and otherwise billed Medicare for unnecessary medical equipment, physical therapy and HIV infusions.

Indictments were issued for 32 people in all, but the status of the other suspects wasn't immediately known.

Miami Dr. Fred Dweck, along with 14 people with whom he worked, was accused in an indictment of running a scam to tap a Medicare program that pays very high rates to care for the sickest patients.

Dweck referred about 1,279 Medicare beneficiaries for expensive and unnecessary home health and therapy services, bribing the owners of two Miami clinics to join the scam. He also faked medical certifications, according to the indictment.

A telephone listing for Dweck could not be found and it was unclear if he had a lawyer.

"No matter what type of fraud is committed, there is one common denominator and that denominator is greed," Assistant Attorney General Lanny Breuer said. "Medicare fraud is not a victimless crime. It hurts every American taxpayer by raising the cost of health care."

The raids come a week after a report that Miami-Dade County received more than half a billion dollars from Medicare in home health care payments intended for the sickest patients in 2008, which is more than the rest of the country combined, according to a report by the Department of Health and Human Services' Office of Inspector General. Medicare paid the county about $520 million, even though only 2 percent of those patients receiving home health care live here.

In Detroit's raids, suspects paid recruiters to find patients willing to feign symptoms to justify expensive testing, including nerve conduction studies, federal authorities said.

A mother and son were charged in Brooklyn with billing Medicare $246 per patient for expensive shoe inserts reserved for diabetes patients, even though they only provided cheap, over-the-counter versions.

Including Tuesday's arrests, a Medicare Fraud strike force formed by the Justice and Health departments has now charged suspects accused of bilking Medicare of more than $1 billion in less than two years.

The pilot strike force, which started in Miami in 2007, has indicted more than 460 suspects in Medicare fraud scams. The program is now in Los Angeles, Houston and Detroit. HHS Secretary Kathleen Sebelius also announced Tuesday the operation will expand to Tampa, Fla., Baton Rouge, La., and Brooklyn.

Cleaning up an estimated $60 billion a year in Medicare fraud will be key to President Barack Obama's proposed health care overhaul. HHS and DOJ have promised more money and manpower to fight the fraud.

Andy Scolnick, VP

Seventh Street Medical Supply, Inc

307 E. Pennsylvania Blvd.

Feasterville, PA 19053

(215) 396-2450

www.seventhstreetmedicalsupply.com

info@seventhstreetmedicalsupply.com

I just received a letter from the CEO and Founder Of the VGM Group, Van G. Miller.

 

It is about time someone with Mr. Miller’s status and position spoke up and starting calling companies out on their actions.

Any consumer out there that is in the need of any type of power mobility product, may it be a scooter, electric wheelchair, or a custom power chair, you better think twice before purchasing one from the SCOOTER STORE. They are also the new owner’s of a company called ALLIANCE SEATING AND MOBILITY.

The Scooter Store commercials look good on TV. The Scooter Stores “Claim to Fame” is they will do all the paper work for you and have a power chair delivered to your home at no cost to you.

I already posted in my last Blog about the downside of receiving medical equipment from locations other than your local reputable medical supply company. The story is the same here; when you need service, you will be looking real hard for help. The salesman’s tactics and sales pitch from these companies are very convincing. It’s almost like you are purchasing a resort timeshare, but I assure you… there are no incentives for you in this deal.

What you also might not know is the Scooter Store has recently made a $17 million False Claims Act “settlement”. If they agreed to settle for 17 million dollars, I can’t imagine how much money this company has swindled out of Medicare and all consumers who have received products from the Scooter Store.

WHO PAYS FOR THIS TYPE OF CONDUCT, WE ALL DO!

The Scooter Store just paid their fine, moved on and in my opinion have not changed any of their questionable tactics.

Why Medicare, Medicaid Beneficiaries and any insurance program still accept billing claims from these two companies is beyond my belief. To all consumers out there, I suggest you think twice before picking up your phone and dialing the Scooter Store or Alliance Seating and Mobility.

Now, to all HME dealers, WAKE UP, SMELL THE COFFEE AND TAKE YOUR HEADS OUT OF THE SAND.

We knew which company has been supplying the Scooter Store. We have heard it for years now from every salesman that sells us scooters and electric wheelchairs.  “PRIDE MOBILITY” I always knew it was Pride Mobility that was selling to the Scooter Store under a no name product.  I admit, I also looked the other way for years. I have walked into Pep Boys and BJ’s and have seen Pride Mobility products.

They completely cut our throat and undersell us on one end and have the audacity to send their reps into our facilities to also buy from them for a more inflated price.

But now, we are in a different and difficult time in our industry, “Competitive Bidding”. The bottom line is Pride Mobility has helped the Scooter Store win bids in all areas where it has become implemented. Many companies have already gone out of business.

I suggest we choose carefully who we buy our products from. I can tell you that Seventh Street Medical Supply, Inc will not be purchasing anything from Pride Mobility. I have completely removed all of their equipment from my catalog.  I will only deal and support companies that will work with me and not undercut me at the same time.

We as HME dealers should take a stance and let it be known that we won’t be fooled any longer.

Mr. Miller, Thank you!

To see Van G. Miller’s letter “Who is on your side”? Click here.

Good Luck to everyone!

Andy Scolnick, VP

Seventh Street Medical Supply, Inc

307 E. Pennsylvania Blvd.

Feasterville, PA 19053

(215) 396-2450

www.seventhstreetmedicalsupply.com

info@seventhstreetmedicalsupply.com

I don’t care how much money you can save by buying equipment through a basement internet site!  DON’T DO IT…

It’s not worth it… There are too many factors and possibilities of malfunction that go wrong with this type of equipment.  I personally see it every day!

·         The hours on units can be reset or replaced.  You have no way of knowing if it is new or used.

·         Items like this are recalled and updates are needed that manufacturers offer.  Every unit that leaves our facility is serialized in case of any type of recall or retrofit that needs to be done.  Only certified dealers will get these notices.

·         Oxygen & CPAP equipment need to be calibrated and checked by a professional technician on a regular basis.  Our office uses and internal diary system to do this task.

·         With CPAP & BIPAP patients, your settings may need to be changed within a week after you receive your new unit.  If your unit was received over the internet, now what are you going to do?

·         4 out of 5 patients don’t like the original CPAP mask they were supplied with.  Our company offers a return policy.

·         Just recently, a major CPAP company that I deal with had bad motor fans.  I did not find this out until calls started to come in from our patient’s complaining of a weird loud noise that was coming out from their unit.   The whole shipment of CPAP & BIPAPS that were sent across the country was bad!  Our company was able to replace these units at our patient’s home the same day.  There is no way possible any “basement internet company” could do that for anyone.  They do not have the recourses available and they have no technical education on this type of equipment to trouble shoot any issues.  In my opinion, they could care less.  It’s all about the initial sale and the buck stops there.

·         All oxygen concentrators have internal filters that need to be changed on periodic intervals.  Our patient’s are set on a diary system and serviced per the individual manufacturer guidelines.

·         ATTENTION ALL OXYGEN PATIENTS THAT HAVE CONCENTRATORS; Just because you feel air coming out of the nasal cannula, doesn’t mean you are getting the proper oxygen in your system.  Our company uses analyzers’ that measure the purity and pressure of oxygen coming out of the units.  On routine basis these things are checked and filters are replaced.  How can any “internet based company” do this for you or a loved one,,,,,, they can’t!

·         I get calls every day at all hours of the day from oxygen and CPAP patients with technical questions and issues.  Some of those questions are solved immediately over the phone and some need immediate assistance at the patient’s home.  No “internet based company” has 24 hour service for in-home emergency services.  They might be able to take a new order, but that’s it.

·         Recently, an oxygen patient came to my office with a regulator he purchased on ebay.  He asked me to look at it for him.  It so happens, it was a regulator that in 2001 was recalled by the FDA.   8 years later this item was still circulating around.  How it found its way on ebay, I can’t imagine.

I have based this blog solely on respiratory equipment, but I assure you it doesn’t stop there.

I see scooters and power chairs everyday on the internet.  What you might not realize is that they also have recalls and optional retrofits that are needed.  There is always some sort of issues with power chairs and scooters.  They are used every day and take a beating. I guarantee you that if you purchase a power vehicle on the internet you will never get any notice that your item needs service.  Several years ago, a major reputable company in our industry that sells power mobility equipment had a recall on their “Tiller Throttle Control”.  The throttle control is the part that you use with your right and left thumb to go forward and backward.  It works on a spring.  Well, the spring was breaking, and needless to say, people were smashing into the walls.  Our company was contacted by the manufacturer with all the serialized scooters that were sent to us.  We were provided all the parts to replace with a new designed spring and PAID by the manufacturer to replace these parts to make the units safe again.  Our company was able to complete this task swiftly before any of our patients were injured.  There is no way any “internet based company” has the recourses or knowledge to have done what we did.

 I can’t stress enough; you need to purchase medical equipment from your local reputable medical supply company.  You owe it to yourself or a family member to at least stop by a neighborhood shop and learn about the ins and outs of the item you’re interested in before the big buy.

If you want to save money by buying something on the internet, buy a pair of shoes!

Seventh Street Medical Supply, Inc has been in business for over 25 years!  We are accredited by The Joint Commission for a reason, WE CARE ABOUT YOU AND WHAT WE DO FOR A LIVING.

Good Luck!

Andy Scolnick, VP

Seventh Street Medical Supply, Inc

307 E. Pennsylvania Blvd.

Feasterville, PA  19053

(215) 396-2450

www.seventhstreetmedicalsupply.com

Never buy medical equipment, especially respiratory equipment on the internet.  Always purchase items from a local reputable medical supply company.  Look for a company that is accredited by the Joint Commission (JCAHO). I have seen and heard too many internet horror stories.  In my opinion, buying medical equipment on the internet is like jumping in the ocean with a bunch of hungry sharks!

Andy Scolnick, VP

Seventh Street Medical Supply, Inc

Being in this business for over 25 years, I have been supplying medical equipment to thousands of patients’ with all different types of illnesses, diseases and injuries.

Recently, some of these illnesses have hit home.  Last year my father had a heart attack, my mother was just diagnosed with Breast Cancer and my close friend’s sister has been battling lung cancer.

Seventh Street Medical Supply is committed to fighting these causes and raising awareness of these diseases. As part of our mission, we ask for your support in recognizing these devastating illnesses. 

Together, we can win this battle.

 To learn more, select any one of the causes below. 

American Heart Association:  Heart Attack Warning Signs
some heart attacks are sudden and intense — the "movie heart attack," where no one doubts what's happening. But most heart attacks start slowly, with mild pain or discomfort. Often people affected aren't sure what's wrong and wait too long before getting help. Here are signs that can mean a heart attack is happening:

• Chest discomfort. Most heart attacks involve discomfort in the center of the chest that lasts more than a few minutes, or that goes away and comes back. It can feel like uncomfortable pressure, squeezing, fullness or pain.   
• Discomfort in other areas of the upper body. Symptoms can include pain or discomfort in one or both arms, the back, neck, jaw or stomach.   
• Shortness of breath with or without chest discomfort.  
• Other signs may include breaking out in a cold sweat, nausea or lightheadedness  www.americanheart.org

Breast Cancer:  Breast cancer is the most common cancer among women in the United States, other than skin cancer. It is the second leading cause of cancer death in women, after lung cancer.

About 182,460 women in the United States will be found to have invasive breast cancer in 2008. About 40,480 women will die from the disease this year. Right now there are about two and a half million breast cancer survivors in the United States.

The chance of a woman having invasive breast cancer some time during her life is about 1 in 8. The chance of dying from breast cancer is about 1 in 35. Breast cancer death rates are going down. This is probably the result of finding the cancer earlier and improved treatment. www.breastcancer.org

Lung Cancer:  Lung cancer is the leading cause of cancer deaths in the United States. Approximately 50% of the people diagnosed with lung cancer have never smoked nor are former smokers. Lung cancer accounts for approximately 29% of all cancer deaths.
During 2008, there will be about 215,020 new cases of lung cancer (114,690 among men and 100,330 among women).  More than 7% of American men and women will be diagnosed with lung cancer in the course of their lifetime. The LUNGevity Foundation:  www.lungevity.org

Andy Scolnick, VP

Seventh Street Medical Supply, Inc

Andy Scolnick, VP

Seventh Street Medical Supply, Inc

H.R. 6331, the Medicare Improvements for Patients and Providers Act of 2008, passed the House of Representatives by a veto-proof margin of 355 to 59. 

I want to thank N.A.M.E.S., PAMS, AAHomecare & everyone involved for their countless efforts that helped support in favor of the H.R. 6331 Bill.

Competitive Bidding for durable medical equipment is officially on hold!

I want to also thank Congressman, Patrick J. Murphy serving Pennsylvania's 8th District for his support.

The Senate is now working on the Medicare package. Call your Senators and tell them the homecare community strongly opposes ANY additional cuts to home medical equipment such as oxygen and power wheelchairs.

Andy Scolnick, VP
Seventh Street Medical Supply

It’s finally here!  The XPO2 Portable Oxygen Concentrator by Invacare has arrived and I have the first shipment.  The XPO2 Portable oxygen concentrator is powered by rechargeable battery packs that offer tremendous advantages over devices that must be plugged in to an AC outlet to run. Most important, they are available for immediate use, anywhere. They can be used indoors, outdoors, or while traveling.

More than half of the one million diagnosed COPD patients are under 65 and are very active.  “When I first saw the AirSep FreeStyle I was excited.  But now, that I have a 5 liter concentrator to offer my patient’s that weighs only 6lbs, I am convinced that this devise will revolutionize the respiratory industry.”

 

The XPO2 will help patients maintain their independence and active lifestyle. The XPO2 weighs 6-lbs with one battery, 7.3-lbs with supplemental battery, so you can simply pick it up on the way out the door.  Eliminate the worry about having enough oxygen cylinders with you. Using the shoulder strap, you simply pick it up and go. With the Invacare Portable XPO2 Concentrator, oxygen patients will experience a new level of freedom, flexibility and peace of mind.

Also, just think, no more waiting for deliveries of oxygen cylinders!  Call me for more information and a demo today. (215) 396-2450 or (800) 723-8110.

Andy Scolnick, VP

Seventh Street Medical Supply